| Mrs Cathleen Walker, RNC, MA, IBCLC | |
|
25 Hettiefred Rd, Greenwich, CT 06831-3258 | |
| (914) 374-2714 | |
| Not Available |
| Full Name | Mrs Cathleen Walker |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Lactation Consultant |
| Location | 25 Hettiefred Rd, Greenwich, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710343249 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WL0100X | Registered Nurse - Lactation Consultant | R55574 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Cathleen Walker, RNC, MA, IBCLC 25 Hettiefred Rd, Greenwich, CT 06831-3258 Ph: (914) 374-2714 | Mrs Cathleen Walker, RNC, MA, IBCLC 25 Hettiefred Rd, Greenwich, CT 06831-3258 Ph: (914) 374-2714 |
News Archive
The scientific ability to quickly and accurately identify species through DNA "barcoding" is being embraced and applied by a growing legion of global authorities - from medical and agricultural researchers to police and customs authorities to palaeontologists and others.
Acarix AB announced the initiation of a multi-center trial of its handheld CADScor System for non-invasive, non-radiation acoustic detection of Coronary Artery Disease.
BioMarin Pharmaceutical Inc. announced today that it has initiated a Phase 1/2 trial for BMN 701, a novel fusion protein of insulin-like growth factor 2 and acid alpha glucosidase in development for the treatment of Pompe disease.
Results of a first-of-its-kind clinical trial shed light on when antibiotics instead of surgery might be the better choice for treating appendicitis in some patients, according to researchers with The University of Texas Health Science Center at Houston, who led the Houston trial sites.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has initiated a new Phase III trial designed to evaluate the efficacy, tolerability and safety of pimavanserin as a treatment for patients with Parkinson's disease psychosis (PDP).
› Verified 9 days ago
Jaclyn Suzanne Porco, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 5 Perryridge Rd, Greenwich, CT 06830 Phone: 212-746-2959 | |
Kristen B Burleson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1391 King St, Greenwich, CT 06831 Phone: 203-246-8411 | |
Brenda Sambrano Cataylo, REGISTERED NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 100 Melrose Ave Ste 206, Greenwich, CT 06830 Phone: 347-578-0196 | |
Ms. Cassandra Krizia Mae Lumucso Zapanta, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 100 Melrose Ave Ste 206, Greenwich, CT 06830 Phone: 860-897-6235 | |
Melissa Giraldez, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5 Perryridge Rd, Greenwich, CT 06830 Phone: 203-863-3510 | |
Sandra Morano, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 78 Bruce Park Ave, Greenwich, CT 06830 Phone: 203-391-8821 | |
Brid Osullivan, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 100 Melrose Ave Ste 206, Greenwich, CT 06830 Phone: 212-532-7620 |